Bristol-Myers Squibb Company (BMY) Management Presents at Leerink Partners Global Biopharma Conference 2024 Conference (Transcript)

Bristol-Myers Squibb Company (NYSE:BMY) Leerink Partners Global Biopharma Conference 2024 Conference Transcript March 13, 2024 10:00 AM ET Executives Samit Hirawat - Executive Vice President, Chief Medical Officer, Head, Development Tim Power - Investor Relations Janet Barth - Investor Relations Analysts Dave Risinger - Leerink Partners Dave Risinger Great. So, good morning, everyone. My name is Dave Risinger. I cover diversified biopharmaceuticals for Leerink Partners and it’s very much my pleasure to welc ...